-- Kulicke & Soffa, Paccar, Rent-A-Center: U.S. Equity Preview
-- B y   I n y o u n g   H w a n g
-- 2012-01-31T14:00:18Z
-- http://www.bloomberg.com/news/2012-01-30/align-hologic-parexel-radioshack-rex-energy-u-s-equity-preview.html
Shares of the following companies
may have unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 8:51 a.m. in  New York .  Post Holdings Inc. (POST-W)  (POST-W US) will replace  Comstock
Resources Inc. (CRK)   in the S&P MidCap 400 Index, and
Comstock will take  THQ Inc. (THQ) ’s (THQI US) place in the S&P
SmallCap 600 Index, after trading closes on Feb. 3, S&P said.  The change is being made because  Ralcorp Holdings Inc. (RAH)   is spinning off Post in a transaction expected to be
completed on or about Feb. 3, S&P said in a statement.  Align Technology Inc. (ALGN)   fell 7.4 percent to $23.50.
The maker of a teeth-straightening product forecast first-
quarter profit excluding some items of no more 21 cents a share,
below the average analyst estimate of 22 cents in a Bloomberg
survey.  Archer-Daniels-Midland Co. (ADM)   declined 4.2 percent to
$28.45. The world’s largest grain processor posted a second-
quarter profit that missed analysts’ estimates after oilseed
earnings fell and corn costs rose.  Biogen Idec Inc. (BIIB)   retreated 1.3 percent to
$115.02. The world’s largest maker of multiple sclerosis
medicines said it sees earnings in 2012 of no more than $6.20 a
share, excluding some items, missing the average analyst
estimate of $6.31.  Ceva Inc. (CEVA)   rose 6.8 percent to $30.01. The chip
designer reported fourth-quarter adjusted earnings of 26 cents a
share, surpassing the average analyst estimate by 4 cents.  Eli Lilly & Co.  (LLY US) advanced 2.8 percent to $40.35.
The pharmaceutical company whose schizophrenia drug Zyprexa lost
patent protection in October said fourth-quarter profit
excluding some items was 87 cents a share, beating the 81-cent
average of 17 analyst estimates compiled by Bloomberg.  Hologic Inc. (HOLX)   added 5.5 percent to $20.25. The
Bedford, Massachusetts-based maker of X-ray systems raised its
2012 profit forecast to as much as $1.38 a share, more than the
average analyst estimate of $1.36 a share.  Kulicke & Soffa Industries Inc.  (KLIC US) lost 7.9 percent
to $10.33. The maker of semiconductor assembly equipment
forecast second-quarter sales to be no more than $135 million,
falling short of the average analyst estimate of $138 million.  Mattel Inc. (MAT)   gained 3.1 percent to $30.45. The
maker of Barbie dolls reported fourth-quarter profit of $1.07 a
share, excluding some items, beating the $1 average analyst
estimate.  Paccar Inc. (PCAR)   gained 5.6 percent to $46.65. The
truckmaker reported fourth-quarter earnings of 91 cents a share,
exceeding the 79-cent average estimate by analysts.  Parexel International Corp. (PRXL)  : The tester of
experimental medicines for drugmakers forecast third-quarter
earnings of as much as 32 cents a share excluding some items,
above the average analyst estimate of 30 cents a share,
according to a Bloomberg survey.  Pfizer Inc. (PFE)   gained 0.3 percent to $21.65. The
world’s largest drugmaker beat analysts’ earnings estimates as
the company’s non-pharmaceutical divisions helped make up for
sales losses from generic competition to its best-seller
Lipitor. The company lowered its 2012 forecast.  RadioShack Corp. (RSH)   plunged 32 percent to $7. The
consumer-electronics retailer suspended share repurchases and
reported preliminary fourth-quarter earnings that trailed
analysts’ estimates. Earnings fell to 11 cents to 13 cents a
share last quarter. Analysts projected 37 cents, the average of
19 estimates compiled by Bloomberg. RadioShack cited
“underperformance” in the  Sprint Nextel Corp. (S)   postpaid
wireless business.  Rent-A-Center Inc. (RCII)  (RCII US) slumped 6.2 percent to $34.90.
The biggest U.S. rent-to-own retailer forecast earnings for 2012
to be no more than $3.20 a share, missing the average analyst
estimate of $3.22.  Rex Energy Corp. (REXX)   erased 8.6 percent to $9.70. The
oil and gas company with operations in the Illinois and
Appalachian basin announced plans for a public offering of 7
million ordinary shares. Additional stock may dilute the value
of existing shares.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  